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The incidence of infectious keratitis was estimated at 34.7 per 100,000 people/year in 
Nottingham (UK), with Pseudomonas aeruginosa being the most common organism. A low 




Background/Aims: To examine the incidence, causative microorganisms, and in vitro 
antimicrobial susceptibility and resistance profiles of infectious keratitis (IK) in Nottingham, 
UK. 
 
Methods: A retrospective study of all patients who were diagnosed with IK and underwent 
corneal scraping between July 2007 and October 2019 (a 12-year period) at a UK tertiary 
referral centre. Relevant data, including demographic factors, microbiological profiles, and in 
vitro antibiotic susceptibility of IK, were analysed.  
 
Results: The estimated incidence of IK was 34.7 per 100,000 people/year. Of the 1333 
corneal scrapes, 502 (37.7%) were culture-positive and 572 causative microorganisms were 
identified. Sixty (4.5%) cases were of polymicrobial origin (caused by 2 different 
microorganisms). Gram-positive bacteria (308, 53.8%) were most commonly isolated, 
followed by Gram-negative bacteria (223, 39.0%), acanthamoeba (24, 4.2%), and fungi (17, 
3.0%). Pseudomonas aeruginosa (135, 23.6%) was the single most common organism 
isolated. There was a significant increase in Moraxella spp. (p<0.001) and significant 
decrease in Klebsiella spp. (p=0.004) over time. The in vitro susceptibility of Gram-positive 
and Gram-negative bacteria to cephalosporin, fluoroquinolone, and aminoglycoside were 
100.0% and 81.3%, 91.9% and 98.1%, and 95.2% and 98.3%, respectively. An increase in 
resistance against penicillin was observed in Gram-positive (from 3.5% to 12.7%; p=0.005) 
and Gram-negative bacteria (from 52.6% to 65.4%; p=0.22). 
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Conclusion: IK represents a relatively common and persistent burden in the UK and the 
reported incidence is likely underestimated. Current broad-spectrum antimicrobial treatment 
provides a good coverage for IK, albeit challenged by some level of antimicrobial resistance 
and polymicrobial infection.  
 
 























Infectious keratitis (IK) represents a major cause of corneal blindness globally, accounting 
for over 5% of all blindness.1 It has also been estimated to cause 1.5-2.0 million monocular 
blindness each year.1 It is a common yet potentially sight-threatening ophthalmic 
emergency, characterised by corneal ulceration, epithelial defect and/or stromal infiltrate. 
Based on the limited evidence in the literature, the incidence of IK has been estimated at 
0.04-8.0 per 1000 people per year, with a substantially higher rate noted in developing 
countries such as India, Nepal, and Burma.1  
 
A wide array of microorganisms, including bacteria, fungi, viruses, and parasites, notably 
acanthamoeba, have been implicated in IK. In view of the diverse causative microorganisms 
and potentially rapid clinical progression, intensive broad-spectrum antimicrobial treatment, 
either with cephalosporin/aminoglycoside dual therapy or fluoroquinolone monotherapy, is 
usually commenced to provide an initial comprehensive coverage for IK.2, 3 Uncommonly, 
adjuvant therapies such as tetracyclines (protease inhibitors), amniotic membrane 
transplantation, and the recently introduced modality of therapeutic corneal cross-linking 
(PACK-CXL) may be required to halt the progression of IK.4-7 
 
The diagnosis of IK is primarily made on clinical grounds, supplemented by microbiological 
investigations such as corneal scraping for microscopy, culture and sensitivity testing.1 
Depending on the geographical and temporal variations, the profile of causative 
microorganisms of IK may differ significantly across different regions.8 For instance, fungi 
were shown to be the most common organism for IK in China and India whereas bacteria 
were most commonly identified in USA and UK.1 In addition, the in vitro antimicrobial 
susceptibility and resistance of ocular isolates similarly varied significantly across the world, 
with the rate of methicillin-resistant Staphylococcus aureus (MRSA) ranging from 0.1% to 
36.6%.9, 10 Moreover, the proportion of multidrug resistant (MDR) ocular isolates is reportedly 
rising in some regions.10 
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To date, there are only two studies in the literature that reported the incidence of IK in the 
UK, which was estimated at 3.6-52.1 per 100,000 population/year during the period of 1995-
2006.11, 12 A number of studies have recently examined the microbiological profiles and/or in 
vitro antibiotic susceptibility and resistance profiles of IK in the UK.9, 13-15 Within the region of 
Nottingham, UK, the most recent review on IK was conducted during the period of 2007-
2010 and only focussed on severe and sight-threatening cases.16  
 
In this study, we aimed to provide an up-to-date and comprehensive analysis on the 
incidence, microbiological profiles, and in vitro antimicrobial susceptibility and resistance of 
IK in Nottingham, UK, over the past 12 years and to compare the findings with the recent 
literature.  
 
MATERIALS AND METHODS 
This was a retrospective study of all patients who were diagnosed with IK and underwent 
corneal scraping between July 2007 and October 2019 (a 12-year period) at the Queen’s 
Medical Centre (QMC), Nottingham, UK. Cases were identified through the local 
microbiology electronic database. QMC was the only tertiary referral centre for managing 
ophthalmic diseases in Nottingham. The eye casualty embedded within the QMC was open 
24/7 to manage patients with emergency ophthalmic conditions, including infectious keratitis. 
There were 2 other nearby hospitals in the East Midlands regions, including Derby Royal 
Hospital and Kings Mill Hospital, but they covered a different subset of the population and 
were not included in Nottingham population or our IK database. 
 
Based on the departmental guideline for IK, all patients presented with moderate sized 
corneal ulcers (>1 mm diameter) or atypical presentation of corneal ulcer were subjected to 
microbiological investigation, which included corneal scraping for microscopy (with Gram 
staining), microbiological culture and sensitivity testing. Corneal scrapes were inoculated on 
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chocolate agar (for fastidious organisms), blood agar (for bacteria), and Sabouraud dextrose 
agar (for fungi). For suspected cases of acanthamoeba keratitis, non-nutrient Escherichia 
coli-enriched agar plate was used for inoculation. All cultures were incubated for at least 1 
week (and up to 3 weeks for suspected acanthamoeba keratitis). The identity of the 
microorganisms was confirmed through standard culture and bacteriology tests. For 
example, S. aureus was identified by cultural characteristics and positive Pasteurex test 
whereas Streptococcus pneumonia was identified by cultural characteristics and sensitivity 
to optochin disc. Corneal scraping was repeated in the same eye when the patient was 
unresponsive to treatment regardless of positive or negative outcome of the first culture. 
These cases were only counted as one clinical episode. 
 
Causative microorganisms were categorised into Gram-positive and Gram-negative 
bacteria, fungi, and acanthamoeba. Polymicrobial keratitis was defined as IK caused by two 
or more types of microorganisms simultaneously during the same infective episode. 
Combined cefuroxime and gentamicin/amikacin were used for deemed sight threatening 
keratitis (greater than 1 mm lesion, location within the central 6 mm zone and/or related to 
contact lens wear); or levofloxacin monotherapy for non-sight threatening keratitis (infiltrate 
size of 1 mm or less, peripheral location and not related to contact lens wear) were the first-
line antimicrobial therapy used during the entire study period. In vitro antimicrobial 
susceptibility and resistance were determined using the standard disc diffusion assay or 
Microscan (MIC) and interpreted according to the clinical breakpoints set by the European 
Committee on Antimicrobial Susceptibility Testing (EUCAST).17 Multidrug resistance (MDR) 
was defined as resistance to three or more classes of antibiotic.  
 
The population in Nottingham was estimated at between 300,000 and 328,000 people during 
the study period (https://www.ukpopulation.org/nottingham-population/), and these figures 
were used to estimate the incidence of IK within the region of Nottingham, UK. For study 
years of 2007 and 2019 (without the full-year data), the incidence was extrapolated from 6 
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months’ and 10 months’ data, respectively. This was because the electronic database was 
only introduced in July 2007 and the study was concluded in October 2019. 
 
Ethical approval was waived by the local research ethics committee as this retrospective 
study was classified as a service evaluation (reference number: 19-265C). The study was 
conducted in accordance with the tenets of Declaration of Helsinki. 
 
Statistical analysis 
For descriptive and analytic purposes, the study was divided into two time periods, 2007-
2013 (which included the study period of previous study)16 and 2014-2019. Statistical 
analysis was performed using SPSS version 26.0 (IBM SPSS Statistics for Windows, 
Armonk, NY, USA). Comparison between groups was conducted using Pearson’s Chi 
square or Fisher’s Exact test where appropriate for categorical variables and unpaired T test 
or Mann-Whitney U test for continuous variables. Normality of data distribution was assumed 
if the skewness and kurtosis z-values were between -1.96 and +1.96 and the Shapiro-Wilk 
test p-value was >0.05. All continuous data were presented as mean  standard deviation 
(SD) and/or 95% confidence interval (CI). Pearson’s correlation coefficient (r) analysis was 
performed to examine the incidence of IK over time and was interpreted as follows: weak 
(r=0.00-0.40), moderate (r=0.41-0.69), and strong (r=0.70-1.00), with negative values being 
interpreted in the same way.18 P-value of <0.05 was considered statistically significant.  
 
RESULTS 
Overall description and incidence of IK 
During the 12-year study period, 1400 corneal scrapes were performed in patients with IK; 
the mean age was 49.9  22.2 years and 50.4% were male. There were 67 cases where 
repeat corneal scrapings were performed in the same eye. On no occasion were both 
cultures positive. After excluding 67 repeat corneal scrapings, there were a total of 1333 
cases of IK. The overall incidence of IK in our region was estimated at 34.7 per 100,000 
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population/year (95% CI, 32.4 to 37.1 per 100,000 population/year), with a stable trend 
observed over time (r = -0.08; p=0.79; Figure 1).  
 
Types of causative organisms 
Of all 1333 cases, 502 (37.7%) were culture-positive and 572 causative microorganisms 
were identified (Table 1). Gram-positive bacteria (308, 53.8%) were most commonly 
isolated, followed by Gram-negative bacteria (223, 39.0%), acanthamoeba (24, 4.2%), and 
fungi (17, 3.0%). In terms of specific isolates, Pseudomonas aeruginosa (135, 23.6%), S. 
aureus (91, 15.9%), and Streptococci spp. (77, 13.5%) were the three most common 
causative microorganisms identified. Sixty (4.5%) cases were of polymicrobial origin (caused 
by 2 different microorganisms), with 50 (3.8%) cases having two causative microorganisms 
and 10 (0.8%) cases having three causative microorganisms. Of the 60 cases, the majority 
(57, 95%) were mixed bacteria / bacteria infection with only 3 (5%) cases of mixed fungi / 
bacteria infection. The most common combination of isolates for polymicrobial cases were 
Streptococci spp. combined with coagulase-negative staphylococcus (9, 15%). There was a 
significant increase in Moraxella spp. (from 2.8% to 10.0%; p<0.001) and significant 
decrease in Klebsiella spp. (from 3.5% to 0.3%; p=0.004) over time.  
 
In vitro antimicrobial susceptibility and resistance profile 
The in vitro antimicrobial susceptibilities for cephalosporin, fluoroquinolone, and 
aminoglycoside were 100.0% (25/25), 91.9% (205/223) and 95.2% (177/186) for Gram-
positive bacteria; and 81.3% (65/80), 98.1% (212/216) and 98.3% (174/177) for Gram-
negative bacteria (Table 2). From 2007-2013 to 2014-2019, there was an increase in 
resistance against penicillin in Gram-positive (from 3.5% to 12.7%; p=0.005) and Gram-
negative bacteria (from 52.6% to 65.4%; p=0.22). There were only four (0.3%) MDR isolates 
and one (0.07%) MRSA noted in this study. Our first-line treatment, either with combined 
therapy (cephalosporin and aminoglycoside) or fluoroquinolone monotherapy, provided good 
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antibiotic coverage for 97.3% (n=396/407) and 95.2% (n=418/439) of the cases, 
respectively.  
 
Antibiotic susceptibility of the four most commonly isolated microorganisms of IK, including 
P. aeruginosa, S. aureus, Streptococci spp., and coagulase-negative staphylococcus, is 
summarised in Table 3. All these organisms were generally susceptible (>90%) to the 
commonly used cephalosporin (i.e. cefuroxime), aminoglycosides, and fluoroquinolones 
used in our study. 
 
Table 1. Summary of microbiological profiles of infectious keratitis in Nottingham, UK, 
between 2007-2013 and 2014-2019.  
Organisms 2007 – 2019 
N=572; N (%) 
2007 – 2013 
N=282; N (%) 
2014 – 2019 
N=290; N (%) 
P-value* 
Gram-positive 
     S. aureus 
     CoNS 
     Streptococci spp. 
     Bacilli 


























     P. aeruginosa 
     Moraxella spp. 
     Klebsiella spp. 






















     Yeast 













Acanthamoeba 24 (4.2) 11 (3.9) 13 (4.5) 0.72 
CoNS = Coagulase-negative staphylococcus 
*Chi-square or Fisher exact test (if any variable was <5) was used to detect any significant changing 
trend of the microbiological profiles between 2017-2013 and 2014-2019. The analysis was performed 
at two levels; the first level evaluated the changes among Gram-positive and Gram-negative 
organisms, fungi and acanthamoeba; and the second level examined the changes of the subtypes of 
the organisms within the four groups. Significant P-values (<0.05) are underlined.  
#Others include Enterococci spp. 
$Others Include Achromobacter spp., Acinetobacter spp., Citrobacter koseri, Enterobacter spp., 





Table 2. Summary of antibiotic susceptibility of infectious keratitis in Nottingham, UK, between 2007-
2013 and 2014-2019. 
Organisms 2007 – 2019 
N (%) 
2007 – 2013 
N (%) 




     Penicillin# 
     Cefuroxime 
     Gentamicin 
     Ciprofloxacin 




























     Penicillin# 
     Cefuroxime 
     Amikacin 
     Gentamicin 
     Ciprofloxacin 





























*Chi-square or Fisher exact test (if any variable was <5) was performed to determine the significant 
difference between the two time periods. Significant p-value is underlined. 
#Penicillin group includes penicillin, amoxicillin, and flucloxacillin. 
 
Table 3. Summary of antibiotic susceptibility of the four most common microorganisms of IK in 
Nottingham, UK, during 2007-2019. 






































CoNS = Coagulase-negative staphylococcus 
#Penicillin group includes penicillin, amoxicillin, and flucloxacillin. 
*Gentamicin and amikacin are aminoglycosides and usually one or the other was tested. 
**Ciprofloxacin and levofloxacin are fluoroquinolone and usually one or the other was tested. 
The percentage shown refers to the antibiotic susceptibility rate of each microorganisms. Rate of 




IK represents a major cause of corneal blindness worldwide, particularly in the developing 
countries. To the best of our knowledge, this represents the third study in the UK that 
reported the incidence as well as the causative microorganisms and in vitro antibiotic 
susceptibility and resistance profiles of IK.  
 
Incidence 
Currently, there is limited literature reporting on the incidence of IK globally. This is mainly 
due to the fact that most studies reported the incidence/prevalence of corneal blindness 
without distinguishing the underlying causes such as infective, inflammatory, traumatic, 
degenerative and others.1 In this study, we observed a stable trend of IK in Nottingham, UK, 
over the past decade (2007-2019), with an estimated incidence of 34.7 per 100,000 
population/year. This figure is comparable to the incidence previously reported in 
Portsmouth, UK, which was 40.1-52.1 per 100,000 population/year during 1997-2006, and 
substantially higher than the rate reported in the West of Scotland, which was 3.6 per 
100,000 population/year during 1995. Consistent with the literature, the incidence of IK 
observed in our study was considerably lower than the rate in developing countries such as 
India and Nepal, which was estimated at 1.1-8.0 per 1000 people (or 110-799 per 100,000 
population/year).19, 20 Such significant variation of the incidence is primarily related to the 
population-based risk factors such as agricultural industry, high-risk occupation (with 
increased risk to corneal trauma), poorer environmental and personal hygiene, lower level of 
education, and poorer access to sanitation and healthcare in the developing countries.1  
 
It is noteworthy to mention that the reported incidence of IK in our study and some other 
studies are likely to be underestimated as it was based on patients with IK who had 
undergone corneal scraping.11 Corneal scraping is usually performed in patients with 
moderate/severe IK with sizeable infiltrate where adequate sampling was possible or in 
patients with mild IK where the clinical presentation was atypical. Based on our local 
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departmental protocol, all patients with a corneal infiltrate of >1mm or those with atypical 
infection were subjected to corneal scraping. This means that patients with mild and typical 
IK were not included in this study. In addition, viral keratitis cases were not captured in this 
study as the majority of cases were treated based on the typical clinical appearance of 
dendritic ulcer without any microbiological investigation. Nonetheless, the relatively stable 
incidence of IK observed in our study during the past decade suggests that IK represents a 
relatively common and persistent burden in the UK.  
 
Microbiological profiles 
Causative microorganisms of IK are subjected to wide geographical variations across the 
world.8 A systematic review of 36 studies demonstrated that bacteria were the most common 
isolates in developed countries whereas fungi were most commonly reported in developing 
countries.8 The recent ACSIKS study, which was conducted in Asia and included over 6000 
patients with IK, demonstrated that fungi were the most common group of causative 
microorganism in China and India whereas bacteria were the most common organism in 
developed countries such as Singapore.21 Another large study conducted in the Southern 
China similarly reported a predominance of fungal keratitis in the region.22 The variation of 
microorganisms is likely influenced by various factors, including the occupational risk of 
corneal trauma, agricultural industry, use of contact lens, national income, and others.1, 8  
 
In our study, we observed that Gram-positive bacteria were the most common group of 
microorganisms responsible for IK during the entire study period. This finding parallels the 
results of many other studies conducted in the UK (Table 4)9, 13-15 and other countries.23-25 
Within the UK, several studies9, 14, 15 have observed that coagulase-negative staphylococcus 
was most commonly isolated, which was in contrast to our study where Pseudomonas spp. 
was the main causative organism (Table 4). This could be related to the differences in 
contact lens wear in different population groups, a fact that was not explored in our study 
and some other studies.9, 13-15 Interestingly, we observed a significant increase trend in   
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Table 4. Summary of the microbiological profiles and antibiotic susceptibility of infectious keratitis in the UK between 2010 and 2019 (based on year of 
publication). 
Year Authors Study 
period 
Region Total CS Culture 
positivity (%) 
Microbiological profiles* Antibiotic susceptibility (%) ** 
PEN  CEF AMG FQ 




Oxford 467 54.0 Pseudomonas spp. (28.5%); 
CoNS (25.8%);  
S. aureus (12.4%) 
50.4 (P) 80.9 (P); 
8.7 (N)  




2017 Tan et al.14  2004 – 
2015  
Manchester 4229 32.6 CoNS (24.4%);  
S. aureus (15.1%); 
Streptococci (13.3%) 






2018 Ting et al.9 2008 – 
2017  
Sunderland 914 44.5 CoNS (25.9%); 
S. aureus (13.6%); 
Streptococci (12.1%) 





Bristol 2614 38.1 CoNS (36.0%); 









2020 Ting et al. 2007 – 
2019  
Nottingham 1333 37.7 Pseudomonas spp. (23.6%);  










CS = Corneal scrapes; PEN = Penicillin; CEF = Cefuroxime; AMG = Aminoglycosides (include gentamicin and amikacin); FQ = Fluoroquinolones 
(include ciprofloxacin, ofloxacin and levofloxacin); CoNS = Coagulase-negative staphylococci 
*The three most common microorganisms isolated in the study. 
**P = Gram-positive bacteria; N = Gram-negative bacteria  
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moraxella keratitis in our region that was similar to other regions in the UK such as 
Sunderland9 and Manchester,14 suggesting a potentially emerging endemic issue within the 
UK. In addition, polymicrobial keratitis presents unique diagnostic and therapeutic 
challenges to the clinicians as the treatment outcome is often variable and the treatment 
course is prolonged.26, 27 We observed 4.5% cases were of polymicrobial keratitis in our 
study, which was lower than the rate reported in the literature (10-14%).9, 14, 22 It would be 
interesting and clinically valuable to examine the clinical outcomes of these polymicrobial 
cases as evidence on this area remains scarce.28  
 
Our culture positivity rate was shown to be 37.7%, which was comparable to some studies14, 
15, 23 but lower than the others.9, 13 Plausible explanations for the relatively low culture yield 
include possible use of antibiotic before the visit to hospital, inadequate sampling from the 
infected corneas, and a lower threshold for performing corneal scrapes in non-infective 
cases, including sterile corneal melt and marginal keratitis. For patients who were already on 
any antibiotics before the hospital visit, our standard practice was to stop all the antibiotics 
for 24-48 hours before performing any corneal scrapes. Therefore, it is likely that any prior 
use of antibiotics would have lesser impact than expected on the culture yield.  
 
Antibiotic susceptibility and resistance 
Antimicrobial resistance (AMR) is emerging as a global health threat of 21st century. AMR 
has been increasingly reported in both systemic and ocular infections.1, 29 In our study, we 
observed a substantial increase in penicillin resistance in both Gram-positive (12.7%) and 
Gram-negative bacteria (65.4%). However, most of the bacterial isolates, including the most 
common organisms, were susceptible to the current broad-spectrum antibiotics (i.e. 
cephalosporin/aminoglycoside dual therapy and fluoroquinolone monotherapy), which was 
similarly reported in other parts of the UK (Table 4).14, 15 Reassuringly, there were only four 
(0.3%) MDR isolates and one (0.07%) MRSA identified in our study.  
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Nonetheless, AMR in relation to IK is emerging as a serious concern in other parts of the 
world, including China,22 USA,25 and India.30, 31 For instance, the rate of MRSA ocular 
isolates was reported to be in the range of 0.1-5.0% in the UK9, 14, 15 whereas Antibiotic 
Resistance Monitoring in Ocular micRoorganisms (ARMOR) study conducted in the USA 
reported a substantially higher rate (36.6%) of MRSA ocular isolates.10 Peng et al.25 
observed that 35% of the ocular isolates were resistant to moxifloxacin and the rate 
increased over time. Similarly, Oldenburg et al.30 and Lalitha et al.31 reported a significant 
increase in fluoroquinolone (ofloxacin / moxifloxacin) resistance among S. aureus and P. 
aeruginosa isolated in South India. In addition, there was a significant increase in the 
number of MRSA from 2002 to 2013 in the same region.31 The discrepancy in the AMR rate 
in ocular isolates observed among different regions may be related to the difference in the 
prescribing practice (e.g. inappropriate and overuse of chloramphenicol eye drops for non-
bacterial eye infection), choice of antibiotics used, environmental transmission, and genomic 
variations in the causative microorganisms. In addition, the variation in the antibiotic 
susceptibility testing method employed in different studies might have an influence on the 
reported results; for instance, broth microdilution minimum inhibitory concentration assays 
were used to determine the antibiotic susceptibility in the ARMOR study10 whereas standard 
disc diffusion assays and/or Microscan were used in our study and other studies.13, 15 
 
Strengths and limitations 
This study provides an up-to-date examination on the incidence of IK in one region of the 
UK. However, the incidence was calculated based on the number of IK cases that had 
corneal scrapings performed, thereby the incidence was likely underestimated. A 
prospective study with inclusion of all presumed IK, including those without corneal scraping, 
could help ascertain the incidence of IK in the future. In addition, the true representation of 
the causative microorganisms is currently challenged by the low-to-moderate yield of the 
conventional microbiological investigation such as corneal scraping. Although our culture 
positivity rate (37.7%) was comparable to some studies, the moderate diagnostic yield 
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highlights the need for further improvement.1 This issue can be potentially ameliorated by 
other emerging investigative techniques such as in vivo confocal microscopy,32, 33 
polymerase chain reaction (PCR) and/or next generation sequencing,34, 35 which have 
demonstrated their values in the diagnosis and clinical decision making in challenging IK 
cases.  
 
Current broad-spectrum antibiotics provide good treatment coverage in most IK cases; 
however, not all the antibiotics used were subjected to antibiotic susceptibility testing. In 
addition, analysis of the susceptibility of chloramphenicol – an over-the-counter antibiotic 
treatment that is routinely prescribed in primary care – was not possible as this was not 
routinely examined in our unit. Reassuringly, a recent UK study did not observe any 
significant increase in resistance against this antibiotic.14 As the commonly used topical 
antibiotics in ophthalmology differs from other specialties, a close collaboration with the 
microbiology department to standardise the in vitro antimicrobial susceptibility testing for IK 
would provide a more comprehensive evaluation of the susceptibility and resistance profiles. 
Although it is beyond the scope of our current study, it would be valuable to examine other 
clinically relevant aspects such as any prior use of antibiotics, causes (e.g. contact lens 
wear, trauma, etc.) and outcomes of IK, in a future study. 
 
In conclusion, IK represents a relatively common and persistent burden in the UK and the 
reported incidence is likely to be underestimated. Current broad-spectrum antimicrobial 
treatment provides good coverage for IK, albeit challenged by some level of antimicrobial 
resistance and polymicrobial infection. Future surveillance of the incidence, causative 
microorganisms, and antimicrobial susceptibility resistance with well-designed prospective 
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Figure 1. The pattern of incidence of infectious keratitis in the region of Nottingham, UK, 
between 2007 and 2019. 
 
